This week on "The Readout LOUD": Why are addiction treatments so hard to get? Ca...
Gilead Sciences has entered an agreement with Merus for the discovery of dual tu...
The challenges and opportunities surrounding Africa becoming a clinical trials g...
The UK NICE has declined to recommend Daiichi Sankyo's Enhertu for the treatment...
Alumis secured $259m in a Series C funding round to develop its clinical-stage p...
J&J submitted a new application to the EMA for the approval of its Darzalex comb...
Discover Avacta Group's groundbreaking patent for therapeutic conjugates with ex...
AI remained one of the main talking points at CTS Europe, as the roadmap for gen...
Citius Pharmaceuticals’ CEO detailed plans to launch its lymphoma therapy Lymphi...
Sionna could have four candidates in clinical trials in 2024, amidst a cystic fi...
Merck has reported a 15.1% decline in net income attributable to shareholders to...
Microplastics found in blood vessels are linked to a greater risk of heart probl...
President Biden wants to more than double the size of Medicare’s new drug price ...
A Senate panel passed a bill aimed at preventing some Chinese biotechs from doin...
The CDC’s new Covid isolation guidance reflects the best way to approach public ...
Will Bayer respond to long-time pressures to separate its drug and agricultural ...
